Search
Search Results
##search.searchResults.foundPlural##
-
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1375PDF: 1305HTML: 96 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4291PDF: 1369HTML: 2039 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3870PDF: 1470HTML: 8513 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1805PDF: 806HTML: 10233Figures 1,2,3: 173 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2446HTML: 270PDF: 867 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1372HTML: 393PDF: 818 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2770PDF: 1807HTML: 3666Pellagatti Fig 1: 214Pellagatti Fig. 2: 209 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6301PDF: 2106HTML: 14012Untitled: 199figure: 184 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3990PDF: 1049HTML: 3589Untitled: 177Cneo. Fig.1: 113Untitled: 104Untitled: 126Untitled: 131 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2078PDF: 1517HTML: 283 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1621PDF: 1092HTML: 117 -
-
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1385PDF: 686HTML: 1079Untitled: 181Untitled: 149Untitled: 131Untitled: 152Untitled: 161 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2319PDF: 984HTML: 7624Untitled: 273Fig2: 183Fig3: 168Fig4: 179 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2167PDF: 1583HTML: 264 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
1954PDF: 821HTML: 2198Table 1: 176Table 2: 195Table 3: 188Table 4: 190Table 5: 187Tble 6: 180Cover Letter: 202Greene Tab.7: 188 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1539PDF: 904HTML: 1952Figure: 169Tables: 185ALL revision 1: 190response to reviewer: 180 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3579PDF: 883HTML: 6710 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3243PDF: 1087HTML: 433 -
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
1291PDF: 609HTML: 229 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1197PDF: 506HTML: 218 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4801PDF: 1796HTML: 2134 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1334PDF: 822HTML: 129 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3246PDF: 1709HTML: 1084 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4736PDF: 2828HTML: 2278 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
968PDF: 533HTML: 722 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3311PDF: 1466HTML: 3998 -
PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome
1080PDF: 759HTML: 291 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2798PDF: 1005HTML: 5519 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2260PDF: 933HTML: 301 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1491PDF: 540HTML: 711







